Cargando…

Baseline gut microbiome impacts probiotics Bacillus licheniformis CMCC63516 in modulating the gut microbiome and preventing antibiotic‐associated diarrhea: A double‐blind, randomized controlled trial

Detalles Bibliográficos
Autores principales: Zhou, Qian, Dai, Wenkui, Bao, Yanmin, Chen, Jing, Han, Xiaohua, Liu, Changshan, Hou, Meijie, Yao, Huisheng, Hao, Changsuo, Li, Shuaicheng, Zheng, Yuejie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076687/
https://www.ncbi.nlm.nih.gov/pubmed/37020353
http://dx.doi.org/10.1002/ctm2.1184
_version_ 1785020186973175808
author Zhou, Qian
Dai, Wenkui
Bao, Yanmin
Chen, Jing
Han, Xiaohua
Liu, Changshan
Hou, Meijie
Yao, Huisheng
Hao, Changsuo
Li, Shuaicheng
Zheng, Yuejie
author_facet Zhou, Qian
Dai, Wenkui
Bao, Yanmin
Chen, Jing
Han, Xiaohua
Liu, Changshan
Hou, Meijie
Yao, Huisheng
Hao, Changsuo
Li, Shuaicheng
Zheng, Yuejie
author_sort Zhou, Qian
collection PubMed
description
format Online
Article
Text
id pubmed-10076687
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-100766872023-04-07 Baseline gut microbiome impacts probiotics Bacillus licheniformis CMCC63516 in modulating the gut microbiome and preventing antibiotic‐associated diarrhea: A double‐blind, randomized controlled trial Zhou, Qian Dai, Wenkui Bao, Yanmin Chen, Jing Han, Xiaohua Liu, Changshan Hou, Meijie Yao, Huisheng Hao, Changsuo Li, Shuaicheng Zheng, Yuejie Clin Transl Med Letter to the Editor John Wiley and Sons Inc. 2023-04-05 /pmc/articles/PMC10076687/ /pubmed/37020353 http://dx.doi.org/10.1002/ctm2.1184 Text en © 2023 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Zhou, Qian
Dai, Wenkui
Bao, Yanmin
Chen, Jing
Han, Xiaohua
Liu, Changshan
Hou, Meijie
Yao, Huisheng
Hao, Changsuo
Li, Shuaicheng
Zheng, Yuejie
Baseline gut microbiome impacts probiotics Bacillus licheniformis CMCC63516 in modulating the gut microbiome and preventing antibiotic‐associated diarrhea: A double‐blind, randomized controlled trial
title Baseline gut microbiome impacts probiotics Bacillus licheniformis CMCC63516 in modulating the gut microbiome and preventing antibiotic‐associated diarrhea: A double‐blind, randomized controlled trial
title_full Baseline gut microbiome impacts probiotics Bacillus licheniformis CMCC63516 in modulating the gut microbiome and preventing antibiotic‐associated diarrhea: A double‐blind, randomized controlled trial
title_fullStr Baseline gut microbiome impacts probiotics Bacillus licheniformis CMCC63516 in modulating the gut microbiome and preventing antibiotic‐associated diarrhea: A double‐blind, randomized controlled trial
title_full_unstemmed Baseline gut microbiome impacts probiotics Bacillus licheniformis CMCC63516 in modulating the gut microbiome and preventing antibiotic‐associated diarrhea: A double‐blind, randomized controlled trial
title_short Baseline gut microbiome impacts probiotics Bacillus licheniformis CMCC63516 in modulating the gut microbiome and preventing antibiotic‐associated diarrhea: A double‐blind, randomized controlled trial
title_sort baseline gut microbiome impacts probiotics bacillus licheniformis cmcc63516 in modulating the gut microbiome and preventing antibiotic‐associated diarrhea: a double‐blind, randomized controlled trial
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076687/
https://www.ncbi.nlm.nih.gov/pubmed/37020353
http://dx.doi.org/10.1002/ctm2.1184
work_keys_str_mv AT zhouqian baselinegutmicrobiomeimpactsprobioticsbacilluslicheniformiscmcc63516inmodulatingthegutmicrobiomeandpreventingantibioticassociateddiarrheaadoubleblindrandomizedcontrolledtrial
AT daiwenkui baselinegutmicrobiomeimpactsprobioticsbacilluslicheniformiscmcc63516inmodulatingthegutmicrobiomeandpreventingantibioticassociateddiarrheaadoubleblindrandomizedcontrolledtrial
AT baoyanmin baselinegutmicrobiomeimpactsprobioticsbacilluslicheniformiscmcc63516inmodulatingthegutmicrobiomeandpreventingantibioticassociateddiarrheaadoubleblindrandomizedcontrolledtrial
AT chenjing baselinegutmicrobiomeimpactsprobioticsbacilluslicheniformiscmcc63516inmodulatingthegutmicrobiomeandpreventingantibioticassociateddiarrheaadoubleblindrandomizedcontrolledtrial
AT hanxiaohua baselinegutmicrobiomeimpactsprobioticsbacilluslicheniformiscmcc63516inmodulatingthegutmicrobiomeandpreventingantibioticassociateddiarrheaadoubleblindrandomizedcontrolledtrial
AT liuchangshan baselinegutmicrobiomeimpactsprobioticsbacilluslicheniformiscmcc63516inmodulatingthegutmicrobiomeandpreventingantibioticassociateddiarrheaadoubleblindrandomizedcontrolledtrial
AT houmeijie baselinegutmicrobiomeimpactsprobioticsbacilluslicheniformiscmcc63516inmodulatingthegutmicrobiomeandpreventingantibioticassociateddiarrheaadoubleblindrandomizedcontrolledtrial
AT yaohuisheng baselinegutmicrobiomeimpactsprobioticsbacilluslicheniformiscmcc63516inmodulatingthegutmicrobiomeandpreventingantibioticassociateddiarrheaadoubleblindrandomizedcontrolledtrial
AT haochangsuo baselinegutmicrobiomeimpactsprobioticsbacilluslicheniformiscmcc63516inmodulatingthegutmicrobiomeandpreventingantibioticassociateddiarrheaadoubleblindrandomizedcontrolledtrial
AT lishuaicheng baselinegutmicrobiomeimpactsprobioticsbacilluslicheniformiscmcc63516inmodulatingthegutmicrobiomeandpreventingantibioticassociateddiarrheaadoubleblindrandomizedcontrolledtrial
AT zhengyuejie baselinegutmicrobiomeimpactsprobioticsbacilluslicheniformiscmcc63516inmodulatingthegutmicrobiomeandpreventingantibioticassociateddiarrheaadoubleblindrandomizedcontrolledtrial